Vericel Corporation

Vericel Corporation (formerly Aastrom Biosciences) is the leader in developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.  The company markets two cell therapy products in the United States, Carticel®  (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns comprising greater than or equal to 30% of total body surface area.  Vericel is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-T, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM).

Category: 

Location
64 Sidney Sreet Domino's Farms, Lobby K
MA 02139 Cambridge
United States
Phone: 617-588-5555
Fax: 617-588-5554
US

Further resources

  • No results

Related articles

Related News

Related events

Related Videos